Sea Crest Wealth Management, LLC Cara Therapeutics, Inc. Transaction History

Sea Crest Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$17.68 - $21.57 $29,578 - $36,086	-1,673 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$14.41 - $19.64 $2,161 - $2,946	-150 Reduced 8.23%	1,673 $33,000
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $8,785 - $11,975	500 Added 37.79%	1,823 $44,000
Q2 2018 Aug 03, 2018	SELL	$11.6 - $19.27 $3,480 - $5,781	-300 Reduced 18.48%	1,323 $25,000
Q1 2018 Apr 20, 2018	SELL	$11.77 - $16.08 $7,062 - $9,647	-600 Reduced 26.99%	1,623 $20,000

Q4 2017 Feb 02, 2018	BUY	$11.86 - $14.08 $26,364 - $31,299	2,223	2,223 $27,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.